NCT03395353View on ClinicalTrials.gov

A Study of Duloxetine (LY248686) in the Treatment of Japanese Children and Adolescents With Depressive Disorder

PHASE3TerminatedINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

January 29, 2018

Primary Completion Date

July 4, 2020

Study Completion Date

July 4, 2020

Conditions
Depressive Disorder
Interventions
DRUG

Duloxetine Hydrochloride

Administered orally

Trial Locations (1)

541-0045

Shionogi, Osaka

Sponsors

Lead Sponsor

Shionogi
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Shionogi

INDUSTRY

NCT03395353 - A Study of Duloxetine (LY248686) in the Treatment of Japanese Children and Adolescents With Depressive Disorder | Biotech Hunter | Biotech Hunter